There will no doubt be some caution about these sorts of claims post-Theranos scandal - however will be interesting to see where this technology goes.
Toshiba developed the diagnosis method together with the National Cancer Center Research Institute and Tokyo Medical University, and hopes to commercialise it in “several years” after starting a trial next year.